Medical AI Quality Assurance Engineering Platform: Practice of End-to-End Test Automation and Intelligent Defect Analysis

This article introduces the healthcare-ai-qa-engineering project, an end-to-end quality assurance engineering platform for the medical AI domain. The project integrates cutting-edge technologies including production-grade frontend, Playwright+Cucumber BDD automated testing, RAG retrieval augmentation, MCP protocol, and LangGraph agents to address the unique challenges of medical AI testing and demonstrate a new paradigm of software testing in the AI era.

Medical AI systems require extremely high reliability, as errors can endanger patients' lives. Traditional testing faces challenges such as the probabilistic nature of AI behavior, data privacy constraints, domain expertise requirements, and black-box characteristics. To address these challenges, this project builds an end-to-end QA platform that combines modern test automation with AI intelligent analysis.

The project adopts a layered architecture: 1. Production-grade frontend simulates real medical scenarios; 2. Playwright+Cucumber BDD implements end-to-end testing, supporting multi-browser and multi-platform, with natural language use cases; 3. Test data management supports data generation, desensitization, and synthesis; 4. AI-driven enhancements: RAG builds a test knowledge base, MCP protocol integrates external AI services, and LangGraph agents orchestrate complex test workflows.

The platform implements AI-driven defect analysis: automatic classification of defect types; assisted root cause analysis (retrieving historical cases + code analysis); generating repair suggestions; trend analysis to identify high-incidence modules and regression risks, forming a closed loop.

Application scenarios cover functional verification, performance testing, regression testing, compatibility testing, and accessibility testing. Technical highlights include CI/CD integration, parallel execution, comprehensive observability, and security compliance (data desensitization, access control, etc.).

The project represents a shift in testing paradigm: from manual execution to intelligent design and supervision; from static use cases to dynamic adaptation; from isolated phases to integrated activities throughout the lifecycle, with reusable test assets.

Current limitations: complex deployment in the medical field, cold start challenges for new projects, and insufficient interpretability of agent decisions. Future directions: introducing medical-specific test models, enhancing agent autonomous decision-making, expanding scenarios, and strengthening compliance support.

This project provides a technical reference for medical AI quality assurance, demonstrating a reliable system combining automation and AI. It offers a testing framework for developers, shows the evolution direction of roles for QA engineers, and proves that AI can enhance testing capabilities. Its concepts will define the next generation of software testing standards.